Autologous CAR-T Cell Manufacturing: Current Standing and Future Directions
A Look at What Drug Manufacturers are Likely Using to Make CAR-T Products
Supplement: MilliporeSigma Sees Opportunity in Continuous Processing
From the GEN Sounds of Science Podcast
Why CAR-T Therapies Don’t Work for Everyone Yet
Selecting the Best Type of T Cells for CAR-T May be Key to the Overall Efficacy of the Therapies
Cell-Centered: Scientists Embrace Cell-Replacement Therapy for Type 1 Diabetes
Forming Beta Cells from Stem Cells
For full access to this article login to GEN Select now.
Quebec Eyes Biotech as Key Growth Sector
Canada’s “Little City” Has Made a Big Investment in Biotechnology and It Seems To Be Paying Off
- Quebec, the “little city” on the St. Lawrence River—little compared to its big sister 60 miles to the southwest, Montreal—is not only home to a wealth of history, spectacular scenery and architecture, and a taste of European culture, but is also becoming a regional hub of excellence in biopharmaceuticals ...
Not registered yet? Please fill out the form below and enjoy complimentary access to this and an exclusive collection of premium content and personalization features as a GEN Select insider. Learn More.
Get GEN Select Access Now
- Do not put any letters or characters here if you are not a spy program.